Nevertheless, increased knowledge of the potential involvement of SPX, PNX, kisspeptin and nesfatin-1 in psychiatric disorders such as BD may help in the future development of therapeutic interventions targeting the signaling pathways of specific neuropeptides. This evidence concerns the gene SMIM20 and Behcet disease.